Authors: Namer, M Soler-Michel, P Turpin, F Chinet-Charrot, P de Gislain, C Pouillart, P Delozier, T Luporsi, E Etienne, PL Schraub, S Eymard, JC Serin, D Ganem, G Calais, G Maillart, P Colin, P Trillet-Lenoir, V Prevost, G Tigaud, D Clavere, P Marti, P Romieu, C Wendling, JL

Citation: M. Namer et al., Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer, EUR J CANC, 37(9), 2001, pp. 1132-1140

Authors: Lagrange, JL Ramaioli, A Theodore, C Terrier-Lacombe, MJ Beckendorf, V Biron, P Chevreau, C Chinet-Charrot, P Dumont, J Delobel-Deroide, A D'Anjou, J Chassagne, C Parache, RM Karsenty, JM Mercier, J Droz, JP

Citation: Jl. Lagrange et al., Non-Hodgkin's lymphoma of the testis: A retrospective study of 84 patientstreated in the French anticancer centres, ANN ONCOL, 12(9), 2001, pp. 1313-1319

Authors: Joly, F Heron, JF Kerbrat, P Chauvergne, J Rios, M Mayer, F Chinet-Charrot, P Goupil, A Lebrun-Jezekova, D Vennin, D Lhomme, C Mace-Lesec'h, J Crouet, H

Citation: F. Joly et al., High-dose platinum versus standard dose in advanced ovarian carcinoma: A randomized trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC), GYNECOL ONC, 78(3), 2000, pp. 361-368

Authors: Lhomme, C Vennin, P Callet, N Lesimple, T Achard, JL Chauvergne, J Luporsi, E Chinet-Charrot, P Coudert, B Couette, JE Guastalla, JP Lebrun, D Ispas, S Blumberg, J

Citation: C. Lhomme et al., A multicenter phase II study with triptorelin (sustained-release LHRH agonist) in advanced or recurrent endometrial carcinoma: A French Anticancer Federation study, GYNECOL ONC, 75(2), 1999, pp. 187-193